Zhdan, V. M.Khaymenova, G. S.Shilkina, L. M.Potyazhenko, M. M.Martynyuk, D. I.Kiryan, Ye. A.Ждан, Вячеслав МиколайовичХайменова, Галина СергіївнаШилкіна, Людмила МиколаївнаПотяженко, Максим МакаровичМартинюк, Дарина ІгорівнаКир'ян, Олена Анатоліївна2017-12-112017-12-112016Modernization of therapy in patients with chronic obstructive pulmonary disease and ischemic heart disease / V. M. Zhdan, G. S. Khaymenova, L. M. Shilkina [et al.] // Clinical Practice (Therapy) : Open Access Journals. – 2016. – Volume 13, nr. 3. – P. 63–66.2044-9038 (Print)2044-9046 (Electronic)DOI 10.4172/clinical-practice.100096https://repository.pdmu.edu.ua/handle/123456789/4169During the combination treatment of chronic obstructive pulmonary disease in association with ischemic heart disease, the increasing attention is paid to pleiotropic effects of statins. Inclusion of rosuvastatin in the treatment regimen allows reducing and stabilizing the main clinical manifestations of this disease constellation, improving the quality of life.enchronic obstructive pulmonary diseasecomorbidityrosuvastatinpleiotropic effectArticle